Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas

Molecular Medicine

Volumn 13, Issue 3-4, 2007, Pages 143-150

  Wu, Rong ^a,b   Coniglio, Salvatore J ^a,b   Chan, Amanda ^a   Symons, Marc H ^a,b   Steinberg, Bettie M ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RAC1 PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX PAPILLOMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RNA INTERFERENCE; UPREGULATION;

CYCLOOXYGENASE 2; HUMANS; MEMBRANE PROTEINS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; RAC1 GTP-BINDING PROTEIN; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY TRACT NEOPLASMS; UP-REGULATION;

EID: 34250638197     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00005.Wu     Document Type: Article

References (32)

1. Gissman L, Diehl B, Schults-Coulon J, zur Hausen H. (1982) Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J. Virol. 44:393-9.
2. Steinberg BM, Meade R, Kalinowski S, Abramson AL. (1990) Abnormal differentiation of human papillomavirus-induced laryngeal Papillomas. Arch. Otolaryngol. Head Neck Surg. 116:1167-71.
3. Poetker DM, Sandler AD, Scott DL, Smith RJ, Bauman NM. (2002) Survivin expression in juvenile-onset recurrent respiratory papillomatosis. Ann. Otol. Rhinol. Laryngol. 111: 957-61.
4. Vambutas A, Di Lorenzo TP, Steinberg BM. (1993) Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res. 53:910-14.
5. Johnston D, Hall H, DiLorenzo TP, Steinberg BM. (1999) Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal Papillomas. Cancer Res. 59:968-74.
6. Wu R, Sun S, Steinberg BM. (2003) Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol. Med. 9:77-84.
7. Zhang P, Steinberg BM. (2000) Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal Papillomas. Cancer Res. 60:1457-62.
8. Sun S, Steinberg BM. (2002) PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J. Gen. Virol. 83:1651-8.
9. Vancurova I, Wu R, Miskolci V, Sun S. (2002) Increased p50/p50 NF-kappaB activation in human papillomavirus type 6- or type 11-induced laryngeal papilloma tissue. J. Virol. 76:1533-6.
10. Wu R, Abramson AL, Shikowitz MJ, Dannenberg AJ, Steinberg BM. (2005) Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory Papillomas. Clin. Cancer Res. 11:6155-61.
11. Subbaramaiah K, Dannenberg AJ. (2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24:96-102.
12. Tolkacheva T, Feuer B, Lorenzi MV, Saez R, Chan AM. (1997) Cooperative transformation of NIH3T3 cells by G alpha12 and Rac1. Oncogene 15:727-35.
13. Kim BC, et al. (1998) Rac GTPase activity is essential for EGF-induced mitogenesis. Mol. Cells 8:90-5.
14. Chan AY, et al. (2005) Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 24:7821-9.
15. Guo F, Debidda M, Yang L, Williams DA, Zheng Y (2006) Genetic deletion of Rac1 GTPase reveals its critical role in actin stress fiber formation and focal adhesion complex assembly. J. Biol. Chem. 281:18652-9. Epub 2006 May 11.
16. Schnelzer A, et al. (2000) Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19:3013-20.
17. Kaempchen - K, Mielke K, Utermark T, Langmesser S, Hanemann CO. (2003) Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Hum. Mol. Genet. 12:1211-21.
18. Iwadate Y, et al. (2004) Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Ress. 264:2496-501.
19. Steinberg BM, Abramson AL, Meade RP. (1982) Culture of human laryngeal papilloma cells in vitro. Otolaryngol. Head Neck Surg. 90:728-35.
20. Laufs U, et al. (2003) Down-regulation of Rac-1 GTPase by estrogen. J. Biol. Chem. 278:5956-62.
21. Davies SP, Reddy H, Caivano M, Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
22. Rane MJ, et al. (2001) p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276:3517-23. Epub 2000 Oct 20.
23. Hess JA, Ross AH, Qiu RG, Symons M, Exton JH. (1997) Role of Rho family proteins in phospholi-pase D activation by growth factors. J. Biol. Chem. 272:1615-20.
24. Marcoux N, Vuori K. (2003) EGF receptor medi-ates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2. Oncogene 22:6100-6.
25. Slice LW, Bui L, Mak C, Walsh JH. (2000) Differential regulation of COX-2 transcription by Ras-and Rho-family of GTPases. Biochem. Biophys. Res. Commun. 276:406-10.
26. Lambert JM, et al. (2002) Tiaml mediates Ras ac-tivation of Rac by a Pl(3)K-independent mechanism. Nature Cell Biol. 4:621-25.
27. Jang BC, et al. (2000) Serum withdrawal-induced post-transcriprional stabilization of cyclooxyge-nase-2 mRNA in MDA-MB-231 mammary carci-noma cells requires the activity of the p38 stress-activated protein kinase. J. Biol. Chem. 275:39507-15.
28. Subbaramaiah K, Marmo TP, Dixon DA, Dannen-berg AJ. (2003) Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involve-ment of p38, MAPKAPK-2, and HuR, J. Biol. Chem. 278:37637-47. Epub 2003 Jun 25.
29. Inoue H, Tanabe T. (1998) Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys. Res. Commun. 244:143-8.
30. Zwerschke W, Jansen-Durr P. (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv. Cancer Res. 78:1-29.
31. Thomas M, Massimi P, Navarro C, Borg JP, Banks L. (2005) The hScrib/DIg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 24:6222-30.
32. Wada T, Penninger JM. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:2838-49.